Quest Diagnostics Inc
DGX178.530USD
+1.849+1.05%
收盤 04/29, 16:00（美東）報價延遲15分鐘
20.00B總市值
23.09本益比TTM
關於 Quest Diagnostics Inc 公司
Quest Diagnostics Incorporated 是一家診斷信息服務提供商。該公司根據實驗室檢測結果提供診斷見解，使人們、醫生和組織能夠採取行動改善健康結果。該公司通過 DIS 部門運營，該部門爲其主要客戶渠道內的一系列客戶提供診斷信息服務：醫生、醫院、患者和消費者。該公司通過全國性的實驗室網絡、患者服務中心、醫生辦公室的採血師和連接資源（包括呼叫中心和移動採血師、護士和其他健康和保健專業人員）提供廣泛的臨牀檢測渠道。該公司還專注於爲生物製藥公司和病理實驗室提供人工智能 (AI) 和數字病理解決方案。該公司已在多個實驗室和業務職能部門實施了人工智能、數字和自動化技術。
公司簡介
公司代碼DGX
公司名稱Quest Diagnostics Inc
上市日期Dec 17, 1996
成立日期1996
CEOMr. James E. (Jim) Davis
員工數量45000
證券類型Ordinary Share
年結日Dec 17
公司地址500 Plaza Drive
城市SECAUCUS
上市交易所NYSE Consolidated
國家United States of America
郵編07094
電話19735202700
網址https://www.questdiagnostics.com/
公司代碼DGX
上市日期Dec 17, 1996
成立日期1996
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
44.41K
+4.88%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
-12.25%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.68K
+2.00%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
25.09K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
16.87K
--
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
12.52K
-16.95%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
10.65K
+0.69%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
5.26K
+1.92%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
1.48K
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
44.41K
+4.88%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
-12.25%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.68K
+2.00%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
25.09K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
16.87K
--
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Routine clinical testing services
5.03B
51.00%
Gene-based and esoteric testing services
3.85B
39.00%
Anatomic pathology testing services
592.32M
6.00%
All other
296.16M
3.00%
COVID-19 testing services
98.72M
1.00%
地區USD
名稱
營收
佔比
United States
9.87B
100.00%
業務
地區
業務USD
名稱
營收
佔比
Routine clinical testing services
5.03B
51.00%
Gene-based and esoteric testing services
3.85B
39.00%
Anatomic pathology testing services
592.32M
6.00%
All other
296.16M
3.00%
COVID-19 testing services
98.72M
1.00%
股東統計
更新時間: 2月21日 週五
更新時間: 2月21日 週五
持股股東
股東類型
持股股東
股東統計
佔比
The Vanguard Group, Inc.
12.46%
BlackRock Institutional Trust Company, N.A.
5.72%
T. Rowe Price Associates, Inc.
4.77%
State Street Global Advisors (US)
4.68%
Victory Capital Management Inc.
3.01%
Other
69.36%
持股股東
股東統計
佔比
The Vanguard Group, Inc.
12.46%
BlackRock Institutional Trust Company, N.A.
5.72%
T. Rowe Price Associates, Inc.
4.77%
State Street Global Advisors (US)
4.68%
Victory Capital Management Inc.
3.01%
Other
69.36%
股東類型
股東統計
佔比
Investment Advisor/Hedge Fund
43.26%
Investment Advisor
39.46%
Research Firm
3.59%
Hedge Fund
2.38%
Pension Fund
2.23%
Bank and Trust
1.51%
Sovereign Wealth Fund
1.20%
Individual Investor
0.44%
Insurance Company
0.10%
Other
5.83%
機構持股
更新時間: 1月20日 週一
更新時間: 1月20日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
1728
104.89M
94.51%
-2.04M
2024Q4
1799
104.71M
94.35%
-2.70M
2024Q3
1750
102.92M
92.46%
-3.55M
2024Q2
1759
102.88M
92.68%
-4.95M
2024Q1
1761
104.07M
93.75%
-1.69M
2023Q4
1784
101.50M
91.43%
-7.03M
2023Q3
1779
103.39M
92.29%
-7.25M
2023Q2
1792
104.49M
93.26%
-6.44M
2023Q1
1797
105.56M
94.19%
-4.32M
2022Q4
1821
104.62M
94.12%
-9.73M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
13.91M
12.54%
-8.04K
-0.06%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
6.38M
5.75%
-47.02K
-0.73%
Dec 31, 2024
T. Rowe Price Associates, Inc.
5.33M
4.8%
+1.63M
+44.23%
Dec 31, 2024
State Street Global Advisors (US)
5.22M
4.71%
-41.76K
-0.79%
Dec 31, 2024
Victory Capital Management Inc.
3.36M
3.03%
-104.37K
-3.01%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.69M
2.42%
+73.37K
+2.80%
Dec 31, 2024
Davis Selected Advisers, L.P.
2.40M
2.16%
-1.84K
-0.08%
Dec 31, 2024
Grantham Mayo Van Otterloo & Co LLC
2.27M
2.04%
+26.21K
+1.17%
Dec 31, 2024
JP Morgan Asset Management
2.12M
1.91%
+986.50K
+87.23%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
2.04M
1.84%
-5.16K
-0.25%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
Global X Telemedicine & Digital Health ETF
4.06%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
3.48%
iShares U.S. Healthcare Providers ETF
2.96%
Madison Dividend Value ETF
2.85%
Davis Select US Equity ETF
2.79%
Monarch Volume Factor Dividend Tree Index ETF
2.75%
First Trust Total US Market AlphaDEX ETF
2.29%
Invesco Bloomberg MVP Multi-Factor ETF
2.21%
Invesco Raymond James SB-1 Equity ETF
2.16%
SPDR S&P Health Care Services ETF
2.03%
查看更多
Global X Telemedicine & Digital Health ETF
佔比4.06%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
佔比3.48%
iShares U.S. Healthcare Providers ETF
佔比2.96%
Madison Dividend Value ETF
佔比2.85%
Davis Select US Equity ETF
佔比2.79%
Monarch Volume Factor Dividend Tree Index ETF
佔比2.75%
First Trust Total US Market AlphaDEX ETF
佔比2.29%
Invesco Bloomberg MVP Multi-Factor ETF
佔比2.21%
Invesco Raymond James SB-1 Equity ETF
佔比2.16%
SPDR S&P Health Care Services ETF
佔比2.03%
分紅派息
近5年累計派現
1.56B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Nov 12, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Jan 29, 2025
Jan 14, 2025
Aug 14, 2024
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Oct 21, 2024
Oct 04, 2024
May 15, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
Jul 08, 2024
Jul 22, 2024
Jul 08, 2024
Feb 01, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
Apr 08, 2024
Apr 22, 2024
Apr 05, 2024
Nov 14, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
Jan 17, 2024
Jan 31, 2024
Jan 16, 2024
Aug 14, 2023
DGX.NB Final Cash Dividend of gross USD 0.71 paid on Oct 23, 2023 going ex on Oct 05, 2023 with reinvestment option
Oct 06, 2023
Oct 23, 2023
Oct 05, 2023
May 16, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jul 25, 2023 going ex on Jul 10, 2023 with reinvestment option
Jul 11, 2023
Jul 25, 2023
Jul 10, 2023
Feb 02, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Apr 24, 2023 going ex on Apr 06, 2023 with reinvestment option
Apr 10, 2023
Apr 24, 2023
Apr 06, 2023
Nov 15, 2022
DGX.NB Interim Cash Dividend of gross USD 0.66 paid on Feb 01, 2023 going ex on Jan 17, 2023
Jan 18, 2023
Feb 01, 2023
Jan 17, 2023
Aug 10, 2022
DGX.NB Final Cash Dividend of gross USD 0.66 paid on Oct 19, 2022 going ex on Oct 03, 2022
Oct 04, 2022
Oct 19, 2022
Oct 03, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據